Elena V. Batrakova obtained a PhD in Polymer Chemistry from the Department of Polymers, M.V. Lomonosov Moscow State University (MSU), Russia. Since 2012, she has been an Associate Professor of Pharmaceutical Sciences at the University of North Carolina at Chapel Hill, USA. For more than twenty years, she has been studying the assembly and applications of drug-loaded nanocarriers. Recently, the main focus of her group is on the development of personalized drug delivery systems by loading therapeutics into immune response cells or extracellular vesicles (EVs) released from these cells. Specifically, her group developed and characterized EV-based drug delivery systems for therapeutic proteins, nucleic acids, and low-molecular chemotherapeutics to treat Parkinson’s disease, stroke, ALS, HIV-related dementia, and cancer. Overall, she has published over 130 papers and filed more than 20 USA and foreign patents on the application of drug delivery systems of biologically active molecules. She is 1 of a total of 10 highly cited scientists at UNC, and a Thomson Reuters agency ranked her in the Top 1% of Highly Cited Researchers.
Elena V. Batrakova obtained a PhD in Polymer Chemistry from the Department of Polymers, M.V. Lomonosov Moscow State University (MSU), Russia. Since 2012, she has been an Associate Professor of Pharmaceutical Sciences at the University of North Carolina at Chapel Hill, USA. For more than twenty years, she has been studying the assembly and applications of drug-loaded nanocarriers. Recently, the main focus of her group is on the development of personalized drug delivery systems by loading therapeutics into immune response cells or extracellular vesicles (EVs) released from these cells. Specifically, her group developed and characterized EV-based drug delivery systems for therapeutic proteins, nucleic acids, and low-molecular chemotherapeutics to treat Parkinson’s disease, stroke, ALS, HIV-related dementia, and cancer. Overall, she has published over 130 papers and filed more than 20 USA and foreign patents on the application of drug delivery systems of biologically active molecules. She is 1 of a total of 10 highly cited scientists at UNC, and a Thomson Reuters agency ranked her in the Top 1% of Highly Cited Researchers.